| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Omega-3 Fatty Acids | Acute Coronary Syndrome | 1 | PM | 33651748 | 📋 | The clinical black, white, and gray lessons |
| Omega-3 Fatty Acids | Acute Coronary Syndrome | 2 | PM | 18556107 | 📋 | Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction |
| Omega-3 Fatty Acids | Aortic Valve Stenosis | 2 | PM | 33304901 | 📋 | Omega-3 Polyunsaturated Fatty Acids and the Resolution of Inflammation: Novel Therapeutic Opportunities for Aortic Valve Stenosis? |
| Omega-3 Fatty Acids | Aortic Valve Stenosis | 1 | PM | 32506925 | 📋 | Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis |
| Omega-3 Fatty Acids | Atrial Fibrillation | 13 | PM | 34702603 | 📋 | Dietary ω-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation |
| Omega-3 Fatty Acids | Atrial Fibrillation | 12 | PM | 34233016 | 📋 | Omega-3 fatty acids in adipose tissue and risk of atrial fibrillation |
| Omega-3 Fatty Acids | Atrial Fibrillation | 1 | PM | 24685324 | 📋 | Omega-3 fatty acids for postoperative atrial fibrillation: alone or in combination with antioxidant vitamins? |
| Omega-3 Fatty Acids | Atrial Fibrillation | 7 | PM | 21123218 | 📋 | Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model |
| Omega-3 Fatty Acids | Atrial Fibrillation | 10 | PM | 20838006 | 📋 | Diet and risk of atrial fibrillation – epidemiologic and clinical evidence – |
| Omega-3 Fatty Acids | Atrial Fibrillation | 9 | PM | 20832129 | 📋 | n-3 polyunsaturated fatty acids prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model |
| Omega-3 Fatty Acids | Atrial Fibrillation | 6 | PM | 20529975 | 📋 | Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery |
| Omega-3 Fatty Acids | Atrial Fibrillation | 8 | PM | 20156610 | 📋 | n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy |
| Omega-3 Fatty Acids | Atrial Fibrillation | 3 | PM | 19898653 | 📋 | Omega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation |
| Omega-3 Fatty Acids | Atrial Fibrillation | 2 | PM | 19629889 | 📋 | Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study |
| Omega-3 Fatty Acids | Atrial Fibrillation | 11 | PM | 19029136 | 📋 | Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes |
| Omega-3 Fatty Acids | Atrial Fibrillation | 4 | PM | 18309477 | 📋 | Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction |
| Omega-3 Fatty Acids | Atrial Fibrillation | 5 | PM | 15893193 | 📋 | N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial |
| Omega-3 Fatty Acids | Cardiac Arrhythmia | 3 | PM | 37454148 | 📋 | A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles |
| Omega-3 Fatty Acids | Cardiac Arrhythmia | 1 | PM | 18556107 | 📋 | Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction |
| Omega-3 Fatty Acids | Cardiac Arrhythmia | 2 | PM | 18328835 | 📋 | Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy |
| Omega-3 Fatty Acids | Cardiac Hypertrophy | 2 | PM | 36410610 | 📋 | Polyunsaturated ω3 fatty acids prevent the cardiac hypertrophy in hypertensive rats |
| Omega-3 Fatty Acids | Cardiac Hypertrophy | 1 | PM | 33498641 | 📋 | Effects of Three-Month Feeding High Fat Diets with Different Fatty Acid Composition on Myocardial Proteome in Mice |
| Omega-3 Fatty Acids | Cardiac Remodeling | 1 | PM | 38136187 | 📋 | The Role of Omega-3 in Attenuating Cardiac Remodeling and Heart Failure through the Oxidative Stress and Inflammation Pathways |
| Omega-3 Fatty Acids | Cardiomyopathy | 4 | PM | 35047577 | 📋 | Cardioprotective Effects of n-3 Polyunsaturated Fatty Acids: Orchestration of mRNA Expression, Protein Phosphorylation, and Lipid Metabolism in Pressure Overload Hearts |
| Omega-3 Fatty Acids | Cardiomyopathy | 3 | PM | 24757612 | 📋 | Effects of omega-3 polyunsaturated Fatty acids on heart function and oxidative stress biomarkers in pediatric patients with dilated cardiomyopathy |
| Omega-3 Fatty Acids | Cardiomyopathy | 1 | PM | 19096109 | 📋 | Positive Inotropic Effect of Coenzyme Q10, omega-3 Fatty Acids and propionyl-L-carnitine on Papillary Muscle Force-Frequency Responses of BIO TO-2 Cardiomyopathic Syrian Hamsters |
| Omega-3 Fatty Acids | Cardiomyopathy | 2 | PM | 18328835 | 📋 | Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy |
| Omega-3 Fatty Acids | Cardiotoxicity | 1 | PM | 34842343 | 📋 | Omega 3 fatty acids can reduce early doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia |
| Omega-3 Fatty Acids | Cardiovascular Damage | 1 | PM | 34684484 | 📋 | Cardiac Oxidative Stress and the Therapeutic Approaches to the Intake of Antioxidant Supplements and Physical Activity |
| Omega-3 Fatty Acids | Cardiovascular Disease | 48 | PM | 38547956 | 📋 | Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases |
| Omega-3 Fatty Acids | Cardiovascular Disease | 47 | PM | 38224465 | 📋 | Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis |
| Omega-3 Fatty Acids | Cardiovascular Disease | 46 | PM | 38169319 | 📋 | Omega-3 Fatty Acids for Cardiovascular Event Lowering |
| Omega-3 Fatty Acids | Cardiovascular Disease | 45 | PM | 38040215 | 📋 | Assessing the Efficacy of Omega-3 Fatty Acids + Statins vs. Statins Only on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of 40,991 Patients |
| Omega-3 Fatty Acids | Cardiovascular Disease | 44 | PM | 38004225 | 📋 | Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease-Possible Causes and Future Considerations |
| Omega-3 Fatty Acids | Cardiovascular Disease | 43 | PM | 37222574 | 📋 | Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials |
| Omega-3 Fatty Acids | Cardiovascular Disease | 42 | PM | 37121469 | 📋 | Effect of omega-3 polyunsaturated fatty acids on cardiovascular outcomes in patients with diabetes: A meta-analysis of randomized controlled trials |
| Omega-3 Fatty Acids | Cardiovascular Disease | 41 | PM | 36795506 | 📋 | Vitamin D3 and omega-3 fatty acids: A new approach for cardiovascular prevention |
| Omega-3 Fatty Acids | Cardiovascular Disease | 40 | PM | 36662586 | 📋 | Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health |
| Omega-3 Fatty Acids | Cardiovascular Disease | 39 | PM | 36621562 | 📋 | Fatty acids act on vascular endothelial cells and influence the development of cardiovascular disease |
| Omega-3 Fatty Acids | Cardiovascular Disease | 38 | PM | 36592188 | 📋 | Intake of marine and plant-derived n-3 fatty acids and development of atherosclerotic cardiovascular disease in the Danish Diet, Cancer and Health cohort |
| Omega-3 Fatty Acids | Cardiovascular Disease | 37 | PM | 36580204 | 📋 | Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues |
| Omega-3 Fatty Acids | Cardiovascular Disease | 36 | PM | 36501174 | 📋 | Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health |
| Omega-3 Fatty Acids | Cardiovascular Disease | 35 | PM | 36431129 | 📋 | Impact of Dietary Fats on Cardiovascular Disease with a Specific Focus on Omega-3 Fatty Acids |
| Omega-3 Fatty Acids | Cardiovascular Disease | 34 | PM | 36103100 | 📋 | Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis |
| Omega-3 Fatty Acids | Cardiovascular Disease | 33 | PM | 35830775 | 📋 | Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality |
| Omega-3 Fatty Acids | Cardiovascular Disease | 32 | PM | 35798287 | 📋 | OMEGA-3 AND CARDIOVASCULAR PREVENTION - IS THIS STILL A CHOICE? |
| Omega-3 Fatty Acids | Cardiovascular Disease | 31 | PM | 35759823 | 📋 | Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention |
| Omega-3 Fatty Acids | Cardiovascular Disease | 30 | PM | 35739003 | 📋 | Omega-3-fatty acids: Do they prevent cardiovascular disease? |
| Omega-3 Fatty Acids | Cardiovascular Disease | 29 | PM | 35690002 | 📋 | A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes |
| Omega-3 Fatty Acids | Cardiovascular Disease | 28 | PM | 35216214 | 📋 | Omega-3 Polyunsaturated Fatty Acids-Vascular and Cardiac Effects on the Cellular and Molecular Level (Narrative Review) |
| Omega-3 Fatty Acids | Cardiovascular Disease | 27 | PM | 35187035 | 📋 | Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials |
| Omega-3 Fatty Acids | Cardiovascular Disease | 26 | PM | 34539977 | 📋 | Effects of omega-3 polyunsaturated fatty acids supplementation for patients with cardiovascular disease risks: a dose-response meta-analysis |
| Omega-3 Fatty Acids | Cardiovascular Disease | 25 | PM | 34505026 | 📋 | Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis |
| Omega-3 Fatty Acids | Cardiovascular Disease | 23 | PM | 34371972 | 📋 | Effects of DHA-Rich n-3 Fatty Acid Supplementation and/or Resistance Training on Body Composition and Cardiometabolic Biomarkers in Overweight and Obese Post-Menopausal Women |
| Omega-3 Fatty Acids | Cardiovascular Disease | 24 | PM | 34371852 | 📋 | Intake of Fish and Marine n-3 Polyunsaturated Fatty Acids and Risk of Cardiovascular Disease Mortality: A Meta-Analysis of Prospective Cohort Studies |
| Omega-3 Fatty Acids | Cardiovascular Disease | 21 | PM | 34191622 | 📋 | Omega-3 Fatty Acids and Cardiovascular Disease: A Narrative Review for Pharmacists |
| Omega-3 Fatty Acids | Cardiovascular Disease | 20 | PM | 33706079 | 📋 | Cardiovascular effects of omega-3 fatty acids: Hope or hype? |
| Omega-3 Fatty Acids | Cardiovascular Disease | 22 | PM | 33693239 | 📋 | Optimal Dose of n-3 Polyunsaturated Fatty Acids for Cardiovascular Event Prevention |
| Omega-3 Fatty Acids | Cardiovascular Disease | 19 | PM | 33660821 | 📋 | Omega-3 fatty acids supplementation on major cardiovascular outcomes: an umbrella review of meta-analyses of observational studies and randomized controlled trials |
| Omega-3 Fatty Acids | Cardiovascular Disease | 18 | PM | 33651748 | 📋 | The clinical black, white, and gray lessons |
| Omega-3 Fatty Acids | Cardiovascular Disease | 17 | PM | 33498799 | 📋 | Increased Omega-3 Fatty Acid Intake Is Inversely Associated with Subclinical Inflammation in Healthy Elderly Men, Based on the 2015-2018 Korean National Health and Nutrition Examination Survey |
| Omega-3 Fatty Acids | Cardiovascular Disease | 16 | PM | 33498729 | 📋 | Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases |
| Omega-3 Fatty Acids | Cardiovascular Disease | 15 | PM | 33445534 | 📋 | An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health |
| Omega-3 Fatty Acids | Cardiovascular Disease | 13 | PM | 33009961 | 📋 | Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction |
| Omega-3 Fatty Acids | Cardiovascular Disease | 3 | PM | 32951855 | 📋 | Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials |
| Omega-3 Fatty Acids | Cardiovascular Disease | 2 | PM | 32634581 | 📋 | OMEGA-3 POLYUNSATURATED FATTY ACIDS SUPPLEMENTATION AND CARDIOVASCULAR OUTCOMES: DO FORMULATION, DOSAGE, AND BASELINE CARDIOVASCULAR RISK MATTER? AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS |
| Omega-3 Fatty Acids | Cardiovascular Disease | 1 | PM | 32546568 | 📋 | Omega-3 for the Prevention of Cardiovascular Diseases: Meta-Analysis and Trial-Sequential Analysis |
| Omega-3 Fatty Acids | Cardiovascular Disease | 6 | PM | 32264876 | 📋 | The intake assessment of diverse dietary patterns on childhood hypertension: alleviating the blood pressure and lipidemic factors with low-sodium seafood rich in omega-3 fatty acids |
| Omega-3 Fatty Acids | Cardiovascular Disease | 9 | PM | 31935118 | 📋 | Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis |
| Omega-3 Fatty Acids | Cardiovascular Disease | 10 | PM | 31582621 | 📋 | Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved |
| Omega-3 Fatty Acids | Cardiovascular Disease | 5 | PM | 31234533 | 📋 | Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System |
| Omega-3 Fatty Acids | Cardiovascular Disease | 4 | PM | 29723102 | 📋 | Cardioprotection by Cocoa Polyphenols and ω-3 Fatty Acids: A Disease-Prevention Perspective on Aging-Associated Cardiovascular Risk |
| Omega-3 Fatty Acids | Cardiovascular Disease | 12 | PM | 28095913 | 📋 | Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia |
| Omega-3 Fatty Acids | Cardiovascular Disease | 14 | PM | 26359712 | 📋 | Cardioprotective mechanism of omega-3 polyunsaturated fatty acids |
| Omega-3 Fatty Acids | Cardiovascular Disease | 11 | PM | 24961394 | 📋 | Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk |
| Omega-3 Fatty Acids | Cardiovascular Disease | 7 | PM | 19593941 | 📋 | Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity |
| Omega-3 Fatty Acids | Cardiovascular Disease | 8 | PM | 18982874 | 📋 | Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics |
| Omega-3 Fatty Acids | Coronary Artery Disease | 11 | PM | 38161115 | 📋 | Effect of omega-3 fatty acids supplementation on the prognosis of coronary artery disease: A meta-analysis of randomized controlled trials |
| Omega-3 Fatty Acids | Coronary Artery Disease | 10 | PM | 38117698 | 📋 | Association between dietary omega-3 intake and coronary heart disease among American adults: The NHANES, 1999-2018 |
| Omega-3 Fatty Acids | Coronary Artery Disease | 3 | PM | 35795375 | 📋 | Effects of ω-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis and Inflammation: A Systematic Review and Meta-Analysis |
| Omega-3 Fatty Acids | Coronary Artery Disease | 9 | PM | 33904996 | 📋 | Associations of dietary patterns and nutrients with coronary artery calcification and pericardial adiposity in a longitudinal study of adults with and without type 1 diabetes |
| Omega-3 Fatty Acids | Coronary Artery Disease | 8 | PM | 33675344 | 📋 | ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial |
| Omega-3 Fatty Acids | Coronary Artery Disease | 7 | PM | 33418065 | 📋 | The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: a meta-regression of randomized clinical trials |
| Omega-3 Fatty Acids | Coronary Artery Disease | 6 | PM | 30513804 | 📋 | The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review |
| Omega-3 Fatty Acids | Coronary Artery Disease | 2 | PM | 20085953 | 📋 | Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease |
| Omega-3 Fatty Acids | Coronary Artery Disease | 1 | PM | 19185299 | 📋 | Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study |
| Omega-3 Fatty Acids | Coronary Artery Disease | 5 | PM | 19092644 | 📋 | Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults |
| Omega-3 Fatty Acids | Coronary Artery Disease | 4 | PM | 12668520 | 📋 | Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women |
| Omega-3 Fatty Acids | Diabetic Cardiomyopathy | 5 | PM | 35717726 | 📋 | The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis |
| Omega-3 Fatty Acids | Diabetic Cardiomyopathy | 4 | PM | 34102283 | 📋 | Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy in rats through autophagic pathway: Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy: Role of autophagy |
| Omega-3 Fatty Acids | Diabetic Cardiomyopathy | 3 | PM | 20071644 | 📋 | Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus |
| Omega-3 Fatty Acids | Diabetic Cardiomyopathy | 1 | PM | 20029543 | 📋 | Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta |
| Omega-3 Fatty Acids | Diabetic Cardiomyopathy | 2 | PM | 19540739 | 📋 | The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients |
| Omega-3 Fatty Acids | Heart Disease | 3 | PM | 38836663 | 📋 | Effect of omega-3 fatty acid supplementation on markers of inflammation and endothelial function in patients with chronic heart disease: A systematic review and meta-analysis |
| Omega-3 Fatty Acids | Heart Disease | 2 | PM | 36213224 | 📋 | Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart |
| Omega-3 Fatty Acids | Heart Disease | 1 | PM | 34201625 | 📋 | Omega-3 Supplementation and Heart Disease: A Population-Based Diet by Gene Analysis of Clinical Trial Outcomes |
| Omega-3 Fatty Acids | Heart Failure | 7 | PM | 38241565 | 📋 | Omega-3 supplementation and outcomes of heart failure: A systematic review of clinical trials |
| Omega-3 Fatty Acids | Heart Failure | 6 | PM | 37340115 | 📋 | Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis |
| Omega-3 Fatty Acids | Heart Failure | 5 | PM | 35321400 | 📋 | Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure |
| Omega-3 Fatty Acids | Heart Failure | 4 | PM | 35241186 | 📋 | Effect of omega-3 polyunsaturated fatty acids on left ventricular remodeling in chronic heart failure: a systematic review and meta-analysis |
| Omega-3 Fatty Acids | Heart Failure | 3 | PM | 34154367 | 📋 | [Effect of omega-3 fatty acids on hypoalbuminemia in acute heart failure patients with increased inflammatory activity] |
| Omega-3 Fatty Acids | Heart Failure | 1 | PM | 32968201 | 📋 | Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart |
| Omega-3 Fatty Acids | Heart Failure | 2 | PM | 19015135 | 📋 | Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction |
| Omega-3 Fatty Acids | Myocardial Infarction | 11 | PM | 38550520 | 📋 | Decreased circulating omega-3 fatty acids increase the risk of myocardial infarction: a two-sample Mendelian randomization study |
| Omega-3 Fatty Acids | Myocardial Infarction | 3 | PM | 33121716 | 📋 | Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction |
| Omega-3 Fatty Acids | Myocardial Infarction | 2 | PM | 33041091 | 📋 | Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial |
| Omega-3 Fatty Acids | Myocardial Infarction | 1 | PM | 32909114 | 📋 | Protective Effect of Boric Acid and Omega-3 on Myocardial Infarction in an Experimental Rat Model |
| Omega-3 Fatty Acids | Myocardial Infarction | 5 | PM | 19148838 | 📋 | Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials |
| Omega-3 Fatty Acids | Myocardial Infarction | 4 | PM | 18614744 | 📋 | Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction |
| Omega-3 Fatty Acids | Myocardial Infarction | 6 | PM | 18556107 | 📋 | Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction |
| Omega-3 Fatty Acids | Myocardial Infarction | 9 | PM | 17237316 | 📋 | Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program |
| Omega-3 Fatty Acids | Myocardial Infarction | 10 | PM | 16979456 | 📋 | Preventing sudden death with n-3 (omega-3) fatty acids and defibrillators |
| Omega-3 Fatty Acids | Myocardial Infarction | 7 | PM | 16087142 | 📋 | Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids |
| Omega-3 Fatty Acids | Myocardial Infarction | 8 | PM | 11997274 | 📋 | Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione |
| Omega-3 Fatty Acids | Myocardial Injury | 3 | PM | 38053947 | 📋 | The Effects of Omega-3 Fatty Acid Supplementation on the Lipid Profile and Cardiovascular Markers Following Downhill Running in Long-Distance Runners |
| Omega-3 Fatty Acids | Myocardial Injury | 2 | PM | 36459842 | 📋 | Omega-3 polyunsaturated fatty acids inhibit cardiomyocyte apoptosis and attenuate sepsis-induced cardiomyopathy |
| Omega-3 Fatty Acids | Myocardial Injury | 1 | PM | 33665922 | 📋 | Fat-1 transgenic mice rich in endogenous omega-3 fatty acids are protected from lipopolysaccharide-induced cardiac dysfunction |
| Omega-3 Fatty Acids | Myocardial Ischemia | 1 | PM | 29806983 | 📋 | A high omega-3 fatty acid diet rapidly changes the lipid composition of cardiac tissue and results in cardioprotection |
| Omega-3 Fatty Acids | Pericarditis | 1 | PM | 20832129 | 📋 | n-3 polyunsaturated fatty acids prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model |
| Omega-3 Fatty Acids | Tachycardia | 4 | PM | 37259986 | 📋 | Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation |
| Omega-3 Fatty Acids | Tachycardia | 3 | PM | 33837412 | 📋 | Chronotropic effects and mechanisms of long-chain omega-3 polyunsaturated fatty acids on heartbeat: the latest insights |
| Omega-3 Fatty Acids | Tachycardia | 1 | PM | 18328835 | 📋 | Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy |
| Omega-3 Fatty Acids | Tachycardia | 2 | PM | 15121409 | 📋 | Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia |
